S-PLEX is MSD’s ultrasensitive assay platform. It can dramatically improve the sensitivity of immunoassays, reducing the lower limit of detection (LLOD) by 10- to 1000-fold over other assay methods. The S-PLEX NHP GFAP Assay has the essential components for an ultrasensitive assay that measures GFAP in a single-analyte format. For detailed instructions on running the GFAP assay, please see the product insert in the "Documentation" tab below.

Related Key Terms:
Glial fibrillary acidic protein, ALXDRD, astrocytes, cytoskeleton structure, blood-brain barrier, Down's syndrome, depression, traumatic brain injury, neurodegeneration, stroke